312 related articles for article (PubMed ID: 28402248)
1. Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
Beigneux AP; Miyashita K; Ploug M; Blom DJ; Ai M; Linton MF; Khovidhunkit W; Dufour R; Garg A; McMahon MA; Pullinger CR; Sandoval NP; Hu X; Allan CM; Larsson M; Machida T; Murakami M; Reue K; Tontonoz P; Goldberg IJ; Moulin P; Charrière S; Fong LG; Nakajima K; Young SG
N Engl J Med; 2017 Apr; 376(17):1647-1658. PubMed ID: 28402248
[TBL] [Abstract][Full Text] [Related]
2. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.
Hu X; Dallinga-Thie GM; Hovingh GK; Chang SY; Sandoval NP; Dang TLP; Fukamachi I; Miyashita K; Nakajima K; Murakami M; Fong LG; Ploug M; Young SG; Beigneux AP
J Clin Lipidol; 2017; 11(4):964-971. PubMed ID: 28666713
[TBL] [Abstract][Full Text] [Related]
3. GPIHBP1 autoantibody syndrome during interferon β1a treatment.
Eguchi J; Miyashita K; Fukamachi I; Nakajima K; Murakami M; Kawahara Y; Yamashita T; Ohta Y; Abe K; Nakatsuka A; Mino M; Takase S; Okazaki H; Hegele RA; Ploug M; Hu X; Wada J; Young SG; Beigneux AP
J Clin Lipidol; 2019; 13(1):62-69. PubMed ID: 30514621
[TBL] [Abstract][Full Text] [Related]
4. Chylomicronemia from GPIHBP1 autoantibodies.
Miyashita K; Lutz J; Hudgins LC; Toib D; Ashraf AP; Song W; Murakami M; Nakajima K; Ploug M; Fong LG; Young SG; Beigneux AP
J Lipid Res; 2020 Nov; 61(11):1365-1376. PubMed ID: 32948662
[TBL] [Abstract][Full Text] [Related]
5. Intermittent chylomicronemia caused by intermittent GPIHBP1 autoantibodies.
Ashraf AP; Miyashita K; Nakajima K; Murakami M; Hegele RA; Ploug M; Fong LG; Young SG; Beigneux AP
J Clin Lipidol; 2020; 14(2):197-200. PubMed ID: 32107180
[TBL] [Abstract][Full Text] [Related]
6. GPIHBP1 and Plasma Triglyceride Metabolism.
Fong LG; Young SG; Beigneux AP; Bensadoun A; Oberer M; Jiang H; Ploug M
Trends Endocrinol Metab; 2016 Jul; 27(7):455-469. PubMed ID: 27185325
[TBL] [Abstract][Full Text] [Related]
7. GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.
Beigneux AP; Fong LG; Bensadoun A; Davies BS; Oberer M; Gårdsvoll H; Ploug M; Young SG
Circ Res; 2015 Feb; 116(4):624-32. PubMed ID: 25387803
[TBL] [Abstract][Full Text] [Related]
8. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.
Beigneux AP; Franssen R; Bensadoun A; Gin P; Melford K; Peter J; Walzem RL; Weinstein MM; Davies BS; Kuivenhoven JA; Kastelein JJ; Fong LG; Dallinga-Thie GM; Young SG
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):956-62. PubMed ID: 19304573
[TBL] [Abstract][Full Text] [Related]
9. Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.
Plengpanich W; Young SG; Khovidhunkit W; Bensadoun A; Karnman H; Ploug M; Gårdsvoll H; Leung CS; Adeyo O; Larsson M; Muanpetch S; Charoen S; Fong LG; Niramitmahapanya S; Beigneux AP
J Biol Chem; 2014 Jul; 289(28):19491-9. PubMed ID: 24847059
[TBL] [Abstract][Full Text] [Related]
10. A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase.
Kristensen KK; Midtgaard SR; Mysling S; Kovrov O; Hansen LB; Skar-Gislinge N; Beigneux AP; Kragelund BB; Olivecrona G; Young SG; Jørgensen TJD; Fong LG; Ploug M
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6020-E6029. PubMed ID: 29899144
[TBL] [Abstract][Full Text] [Related]
11. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.
Young SG; Fong LG; Beigneux AP; Allan CM; He C; Jiang H; Nakajima K; Meiyappan M; Birrane G; Ploug M
Cell Metab; 2019 Jul; 30(1):51-65. PubMed ID: 31269429
[TBL] [Abstract][Full Text] [Related]
12. GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
Young SG; Davies BS; Voss CV; Gin P; Weinstein MM; Tontonoz P; Reue K; Bensadoun A; Fong LG; Beigneux AP
J Lipid Res; 2011 Nov; 52(11):1869-84. PubMed ID: 21844202
[TBL] [Abstract][Full Text] [Related]
13. A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism.
Young SG; Song W; Yang Y; Birrane G; Jiang H; Beigneux AP; Ploug M; Fong LG
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2211136119. PubMed ID: 36037340
[TBL] [Abstract][Full Text] [Related]
14. Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1.
Voss CV; Davies BS; Tat S; Gin P; Fong LG; Pelletier C; Mottler CD; Bensadoun A; Beigneux AP; Young SG
Proc Natl Acad Sci U S A; 2011 May; 108(19):7980-4. PubMed ID: 21518912
[TBL] [Abstract][Full Text] [Related]
15. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia.
Strøm TB; Tveita AA; Bogsrud MP; Leren TP
J Clin Lipidol; 2024; 18(1):e80-e89. PubMed ID: 37981531
[TBL] [Abstract][Full Text] [Related]
17. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.
Adeyo O; Goulbourne CN; Bensadoun A; Beigneux AP; Fong LG; Young SG
J Intern Med; 2012 Dec; 272(6):528-40. PubMed ID: 23020258
[TBL] [Abstract][Full Text] [Related]
18. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.
Franssen R; Young SG; Peelman F; Hertecant J; Sierts JA; Schimmel AW; Bensadoun A; Kastelein JJ; Fong LG; Dallinga-Thie GM; Beigneux AP
Circ Cardiovasc Genet; 2010 Apr; 3(2):169-78. PubMed ID: 20124439
[TBL] [Abstract][Full Text] [Related]
19. Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysis.
Birrane G; Beigneux AP; Dwyer B; Strack-Logue B; Kristensen KK; Francone OL; Fong LG; Mertens HDT; Pan CQ; Ploug M; Young SG; Meiyappan M
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1723-1732. PubMed ID: 30559189
[TBL] [Abstract][Full Text] [Related]
20. The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain.
Mysling S; Kristensen KK; Larsson M; Beigneux AP; Gårdsvoll H; Fong LG; Bensadouen A; Jørgensen TJ; Young SG; Ploug M
Elife; 2016 Jan; 5():e12095. PubMed ID: 26725083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
